Company news

Avalo Therapeutics, Inc. news in 2022

Avalo Therapeutics, Inc.'s news releases, calls and decks from 2022, newest first.

View company

Avalo Sells Economic Rights to Previously Out-Licensed Assets for $5 Million

November 6, 2022

Avalo Reports Third Quarter 2022 Financial Results and Provides Business Updates

November 6, 2022

Avalo Advances BTLA Agonist Fusion Protein (AVTX-008) to IND-enabling Stage

September 5, 2022

Avalo to Present at the H.C. Wainwright Global Investment Conference

August 31, 2022

Avalo Therapeutics Announces Board Changes

August 10, 2022

Avalo Reports Second Quarter 2022 Financial Results and Provides Business Updates

August 3, 2022

Avalo Therapeutics Announces First Patient Dosed in the AVTX-803 Pivotal Trial (LADDER) for the Treatment of Leukocyte Adhesion Deficiency Type II (LAD II)

August 1, 2022

Avalo Therapeutics Transfers Anti-IL-18 Antibody, AVTX-007 (camoteskimab) to Apollo Therapeutics

July 31, 2022

Avalo Therapeutics Announces One-for-Twelve Reverse Stock Split

July 5, 2022

Avalo to Present at the 2022 Jefferies Healthcare Conference

June 1, 2022

Avalo Therapeutics Announces First Patient Dosed in the Phase 2 PEAK Trial of AVTX-002 for the Treatment of Non-Eosinophilic Asthma (NEA)

May 17, 2022

Avalo to Present at the H.C. Wainwright Global Life Sciences Conference

May 16, 2022

Avalo Therapeutics First Quarter 2022 Financial Results and Business Updates

May 4, 2022

Avalo to Present at Oppenheimer's 32nd Annual Healthcare Conference

March 7, 2022

Avalo Therapeutics Reports 2021 Financial Results and Provides Business Updates

March 1, 2022

Avalo Therapeutics Announces Leadership Transition

February 16, 2022

Avalo Therapeutics to Present at the 2022 BIO CEO and Investor Conference

February 6, 2022

Avalo Therapeutics Appoints Stephen Smolinski as Chief Commercial Officer

January 9, 2022

Avalo Reports Positive Phase 1b Results for AVTX-002 in Moderate to Severe Crohn's Disease Patients and Presents Additional Program Updates at 2022 Investor Event

January 5, 2022

Decks in 2022